Syros Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Welcome to Oppenheimer's 31st Annual Healthcare Conference. My name is Mark Breidenbach. I'm part of the biotech equity research team. Our next presenting company is Syros, which is developing small molecule therapies for cancer and rare disease, and I'm delighted to introduce the company's CFO, Joe Ferra, who is going to walk us through the story this morning. Joe, why don't you take it away.
Thank you, Mark. I appreciate it, and thank you, everyone, for joining us today. And a big thank you to the Oppenheimer team for giving us an opportunity to present. As Mark mentioned, I'm the CFO of Syros. During this presentation, I will be making some forward-looking statements. For a complete review of our risk factors, I invite you to visit our website at www.syros.com. While you are there, please be sure to check out the blog
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
